Pharmacists in Watkins Glen, NY Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Tyler John Bogardus Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-535-7350

Dr. Bradley Allen, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-972-3207

Dr. Kevin John Gillon, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-535-7350

Eileen S Bontorno Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 N Franklin St, Watkins Glen, NY 14891 Phone: 607-535-4999    Fax: 518-463-4514

Lindsey Wratten Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-535-7350

Mrs. Cindy S. Finch, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 E 4th St, Watkins Glen, NY 14891 Phone: 607-535-3125

David John Krazinski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 E 4th St, Watkins Glen, NY 14891 Phone: 607-535-3125    Fax: 607-535-3129

Dr. Alyssa Kay Bubniak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 E 4th St, Watkins Glen, NY 14891 Phone: 607-535-3125

Trevor Carey, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-535-7350    Fax: 607-535-2663

Mrs. Patricia Anne Cunningham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 N Franklin St Fl 2, Watkins Glen, NY 14891 Phone: 607-535-4999    Fax: 607-535-4320

Dr. Nicholas Edwin Jennings, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 506 S Franklin St, Watkins Glen, NY 14891 Phone: 607-535-7350    Fax: 607-535-2663

News Archive

TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses

Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.

Advanced understanding of neurodegenerative diseases achieved by Trophos

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the conclusion of the pan-European MitoTarget Project, the EU funded orphan disease project, with submission of the final report to the EC.

President to unveil $3.7 billion budget blueprint; challenge is to show fiscal discipline while funding health law's implementation

President Barack Obama's budget plan includes a two-year Medicare "doc-fix" that uses heavy cuts in other health providers' Medicare reimbursements to stave-off a scheduled 25 percent reduction in Medicare physician reimbursements. Meanwhile, news outlets also report the plan "avoids" tackling entitlement spending.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Read more Medical News

› Verified 2 days ago